MétaCan
Menu
← Back to cohort
Record W2117872020 · doi:10.3899/jrheum.080399

New Onset of Inflammatory Polyarthritis in a Patient Taking Adalimumab

2009· letter· en· W2117872020 on OpenAlexaffvenue
Monica Lee, Rima Petronienė, Carter Thorne

Bibliographic record

VenueThe Journal of Rheumatology · 2009
Typeletter
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicInflammatory Bowel Disease
Canadian institutionsRoyal Victoria Regional Health CentreSouthlake Regional Health CenterUniversity of Toronto
Fundersnot available
KeywordsMedicineAdalimumabPolyarthritisDermatologyArthritisInflammatory arthritisInternal medicineRheumatoid arthritis

Abstract

fetched live from OpenAlex

To the Editor:Rare cases of paradoxical adverse effects associated with the use of tumor necrosis factor-α (TNF-α) antagonists have been reported.We describe a case of new-onset inflammatory polyarthritis associated with the use of adalimumab in the treatment of Crohn's disease (CD).A 64-year-old woman with a 10-year history of CD presented with a new onset of symmetrical polyarthritis while being treated with adalimumab.Previous treatment for CD included oral budesonide, prednisone, 5-aminosalicylic acid, and azathioprine; surgery for bowel obstruction had occurred 10 years earlier.Her history was significant for bilateral carpal tunnel release 3 years previously; there was no other history of arthritis, including peripheral arthritis, dactylitis, enthesitis, or axial complaints.The treatment regimen of adalimumab was 160 mg on Day 1, 80 mg on Day 15, and 40 mg every 2 weeks thereafter.She was not taking any other medications known to induce polyarthritis.After 12 weeks of therapy, she developed acute severe "muscle pain" in the upper and lower extremities.She denied muscle weakness.Joint swelling was reported as "absent" by another clinician, but she had some "joint pain."There were no associated fevers, rashes, or prodromal illnesses.Laboratory tests showed a positive antinuclear antibody of 1:160 titer (extractable nuclear antigen and anti-dsDNA were negative), rheumatoid factor of 8 kIU/l, C-reactive protein of 48 mg/l (normal ≤ 7 mg/l), erythrocyte sedimentation rate 15 mm/h, and hemoglobin 119 g/l (anti-cyclic citrullinated peptide measurement was not available).Platelet count and liver function tests were normal.She did not fulfill 4 or more classification criteria for systemic lupus erythematosus.Her adalimumab was discontinued immediately.She described her Crohn's condition to be well controlled while undergoing therapy with adalimumab.After discontinuation of adalimumab, she had no recurrence of gastrointestinal symptoms, but continued to have "severe muscle discomfort" and was referred to a rheumatologist (CT) for assessment.On examination, she had palmar erythema, which she reported as long-standing.A general system examination was unremarkable.No skin, scalp or nail lesions of psoriasis, mucosal lesions, or hepatosplenomegaly were noted.She denied articular morning stiffness.Grip strength was 180/170, right-handed.Active joint count included 40 tender with 14 swollen joints.The swollen joints were in the small joints of both hands, both wrists, and right elbow with a 20° flexion deformity, both knees with a bulge sign, and stress pain in the ankles.No enthesitis or dactylitis was noted, and axial examination was noncontributory.Decreased range of

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.007
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Case report · Consensus signal: Case report
GenreCandidate signal: Other · Consensus signal: none
Teacher disagreement score0.010
Threshold uncertainty score0.010

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.007
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0020.001
Scholarly communication0.0010.002
Open science0.0010.001
Research integrity0.0100.005
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.006
GPT teacher head0.219
Teacher spread0.213 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designCase report
Domainnot available
GenreOther

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2009
Admission routes2
Has abstractyes

Explore more

Same venueThe Journal of Rheumatology→Same topicInflammatory Bowel Disease→French-language works237,207→